STAMPANONI BASSI, MARIO ALBERTO UGO
 Distribuzione geografica
Continente #
AS - Asia 957
NA - Nord America 823
EU - Europa 593
SA - Sud America 242
AF - Africa 28
Totale 2.643
Nazione #
US - Stati Uniti d'America 738
SG - Singapore 325
DE - Germania 238
CN - Cina 225
BR - Brasile 179
HK - Hong Kong 155
IT - Italia 102
FR - Francia 82
VN - Vietnam 69
DO - Repubblica Dominicana 45
KR - Corea 43
RU - Federazione Russa 42
GB - Regno Unito 35
BD - Bangladesh 29
FI - Finlandia 28
IN - India 26
AR - Argentina 24
CA - Canada 23
TR - Turchia 14
EE - Estonia 13
ID - Indonesia 12
IQ - Iraq 12
MX - Messico 12
PL - Polonia 11
NL - Olanda 10
CO - Colombia 9
ZA - Sudafrica 9
EC - Ecuador 8
ES - Italia 8
PK - Pakistan 8
UZ - Uzbekistan 8
EG - Egitto 7
BE - Belgio 6
JP - Giappone 6
PE - Perù 5
SA - Arabia Saudita 5
VE - Venezuela 5
CL - Cile 4
MA - Marocco 4
UA - Ucraina 4
UY - Uruguay 4
BH - Bahrain 3
JM - Giamaica 3
KE - Kenya 3
NP - Nepal 3
PY - Paraguay 3
RS - Serbia 3
SE - Svezia 3
AL - Albania 2
AT - Austria 2
AZ - Azerbaigian 2
OM - Oman 2
PH - Filippine 2
AM - Armenia 1
BB - Barbados 1
CH - Svizzera 1
CM - Camerun 1
CR - Costa Rica 1
DZ - Algeria 1
GY - Guiana 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MY - Malesia 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
UG - Uganda 1
Totale 2.643
Città #
San Jose 238
Singapore 196
Hong Kong 155
Falkenstein 131
Ashburn 116
Beijing 83
Frankfurt am Main 76
West Jordan 50
Rome 45
Chicago 44
Seoul 43
Sosua, Cabarete 43
Lauterbourg 38
Dallas 35
Boardman 33
Ho Chi Minh City 28
Munich 19
Los Angeles 17
Moscow 17
Turku 17
São Paulo 15
Toronto 12
Buffalo 11
Helsinki 11
Orem 11
Santa Clara 10
Rio de Janeiro 9
New York 8
Tashkent 8
Belo Horizonte 7
London 7
Montreal 7
Brooklyn 6
Brussels 6
Charlotte 6
Curitiba 6
Mexico City 6
Naples 6
San Francisco 6
Suzhou 6
Tokyo 6
Warsaw 6
Bexley 5
Chennai 5
Dhaka 5
Hanoi 5
Hillsboro 5
Ankara 4
Bogotá 4
Bologna 4
Brasília 4
Cairo 4
Hải Dương 4
Manchester 4
Montevideo 4
Mumbai 4
Porto Alegre 4
Quito 4
Sant'Elpidio a Mare 4
The Dalles 4
Wroclaw 4
Amsterdam 3
Arosio 3
Atlanta 3
Baghdad 3
Belgrade 3
Cape Town 3
Da Nang 3
Denver 3
Erbil 3
Ettlingen 3
Galbiate 3
Guayaquil 3
Istanbul 3
Ituzaingó 3
Jeddah 3
Lima 3
Mar del Plata 3
Milan 3
Nairobi 3
Ninh Bình 3
Ottawa 3
Quảng Ngãi 3
Anápolis 2
Aracaju 2
Asunción 2
Bauru 2
Bekasi 2
Buenos Aires 2
Bình Dương 2
Carapicuíba 2
Council Bluffs 2
Diano d'Alba 2
Eagleville 2
Giza 2
Guarulhos 2
Gujranwala 2
Haiphong 2
Hamad Town 2
Hyderabad 2
Totale 1.781
Nome #
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 112
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 94
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 93
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 92
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 89
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 89
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 88
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 85
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 81
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 72
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 72
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients. 71
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 69
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 66
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 65
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 65
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 63
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis. 63
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 61
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 61
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 61
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 60
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 58
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 58
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 56
Obesity worsens central inflammation and disability in multiple sclerosis 56
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 55
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 55
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 54
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 53
Case Report: Overlap Between Long COVID and Functional Neurological Disorders 53
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 52
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 50
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 50
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 50
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 48
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 47
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 47
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 45
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 44
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 41
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 40
Subclinical dysphagia in task-specific mouth tremor triggered by drinking 34
Totale 2.718
Categoria #
all - tutte 13.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024164 0 0 0 0 0 0 37 0 0 101 15 11
2024/2025742 28 43 7 45 69 42 164 156 41 28 110 9
2025/20261.812 149 158 224 259 98 70 324 215 212 103 0 0
Totale 2.718